After the UN High-level Meeting on Tuberculosis last fall, MSF sharply criticized major donor and high-donor countries for empty promises to end TB—the world’s leading infectious disease killer.
MSF is keeping up the pressure with a series of events this week, including a regional symposium in Uzbekistan wrapping up today and a webcast earlier this week featuring MSF and McGill University TB experts.
Rachel Kiddell-Monroe, a McGill University professor, collected their wish list to end the scourge:
- A more friendly treatment regimen free of all injectable (highly toxic, inefficient) drugs—Serge Kabore, MSF physician and Telemedicine Medical Team manager
- Improvement of socioeconomic conditions worldwide—Noémie Savard, epidemiologist, MSF
- An effective vaccine—which would eliminate the challenges with treatment and drug-resistant strains and a way to identify people with latent TB who are likely to develop active TB—Kevin Schwartzman, director of the Respiratory Division, McGill University. He also explains (at 36:16) why a TB vaccine has proved so frustratingly elusive.